Search

Your search keyword '"Pastorino, Lorenza"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Pastorino, Lorenza" Remove constraint Author: "Pastorino, Lorenza"
286 results on '"Pastorino, Lorenza"'

Search Results

1. Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

2. Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.

4. Genetic telecounseling: evaluation of efficacy and outcomes through the Genetic Counseling Outcome Scale (GCOS) questionnaire in a cohort of patients with a suspected melanoma susceptibility syndrome

5. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

6. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

8. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer

13. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup

14. Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting

15. Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma

16. Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations

18. Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients

19. Cancer risk and tumour spectrum in 172 patients with a germlineSUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group

20. MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy

21. The CDKN2A/p16INK4a 5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

22. Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt–Hogg–Dubè Syndrome Family

24. Clinical genetic testing for familial melanoma in Italy: A cooperative study

27. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

30. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants

32. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families

35. Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

36. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

37. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries

40. Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome

41. MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

42. Cancer risk and tumour spectrum in 172 patients with a germline SUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group

43. Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project

44. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).

45. Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.

46. Comprehensive Study of the Clinical Phenotype of GermlineBAP1Variant-Carrying Families Worldwide

47. Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations

48. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma

49. Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations

50. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

Catalog

Books, media, physical & digital resources